In March 2025, the company introduced new options for the direct-to-client giving of its Wegovy weight loss drug. The company established a whole new pharmacy, identified as NovoCare, which might cost consumers $499 per 30 days for use of the drug, fewer than 50 percent the price of the drug through other pharmaceutical distribution networks.[fifty